Our cytology department processes over 85,000 gynecologic specimens annually using liquid based technology. We use an FDA approved automated digital imaging system for the detection and evaluation of abnormal cervical cells.
Our staff of highly trained pathologists, cytotechnologists, and clinical laboratory scientists is focused on ensuring quality result reporting by correlating patient history and cervical biopsy information. Monthly summary reports are provided to clients.
The liquid based specimen can also be used for HPV 16 and 18/45 genotyping, Chlamydia and Gonorrhea, and Trichomoniasis.